AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

IntelliAM AI Plc

Regulatory Filings Oct 27, 2025

10321_rns_2025-10-27_6c1067e3-9983-4bc2-9831-9c05a0b33d66.html

Regulatory Filings

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 9190E

IntelliAM AI PLC

27 October 2025

27 October 2025

IntelliAM AI PLC

Admission to the Apex segment of the AQSE Growth Market

IntelliAM AI (AQSE: INT) ("IntelliAM" or the "Company"), the specialist in AI-driven asset management, empowering industrial operations to cut costs and enhance productivity, is pleased to announce that it is eligible for its ordinary shares to commence trading on the Apex segment of the Aquis Stock Exchange ("AQSE") with effect from 3 November 2025.

The Apex segment caters for larger, more established businesses, and enforces stricter eligibility criteria to encourage greater liquidity and transparency.

IntelliAM, which first listed on AQSE in July 2024, satisfies the qualifying criteria for its ordinary shares to trade on the Apex segment, including:

·    A minimum market capitalisation of £10 million.

·    At least 2 active market makers.

·    A minimum 2 years' trading history.

·    High standards of Corporate Governance Code compliance and disclosures.

At the date of this announcement, shares representing 22.9% of the Company's issued share capital are in public hands.  Notwithstanding the current free float, Aquis has approved a derogation to the Apex free float requirement of 25%, given the institutional investor support the Company has received since IPO, the significant strategic progress recently announced, including a co-development Partnership Agreement with a global engineering manufacturer (as announced 24 September 2025) and the major expansion of its commercial partnership with Hovis Limited (as announced 1 October 2025) and the immaterial variance of only 2.1% below the 25% threshold requirement.

Tom Clayton, Founder and CEO of IntelliAM AI plc, said:

"I am delighted to now be part of the Apex segment on the Aquis Growth Market. Our move to the Apex segment will provide further visibility to our existing and prospective investors, and we welcome the increased emphasis on transparency, liquidity, and corporate governance, which is entirely aligned with IntelliAM's strategy."

David Stevens, CEO Aquis Exchange, said:

"We are delighted to see IntelliAM's move up to the Apex segment of the Aquis Stock Exchange Growth Market. It's fantastic to see how the company has progressed so far, and I am proud that Aquis can offer a tailored experience for growth companies that allows for increased exposure to investors at appropriate stages."

Enquiries:
IntelliAM AI plc

Tom Clayton, Chief Executive Officer

Daud Khan, Chief Financial Officer
+44 114 299 5007
Oberon Capital - AQSE Corporate Adviser and Broker              

Nick Lovering

Adam Pollock

Mike Seabrook
+44 203 179 5300
Square1 Consulting - Financial PR

David Bick
+44 207 929 5599

+44 7831 381201

Ends

About IntelliAM AI:

IntelliAM AI plc specializes in developing AI-powered software solutions for the manufacturing industry. The IntelliAM platform harnesses the power of machine learning to optimize industrial asset management, improve productivity, and reduce operational costs. For more information, visit  www.intelliam.com .

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NEXPPGMPUUPAUMM

Talk to a Data Expert

Have a question? We'll get back to you promptly.